Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1455218
Reference Type
Journal Article
Title
Effects of Ficus hirta Vahl. (Wuzhimaotao) extracts on growth inhibition of HeLa cells
Author(s)
Zeng, YW; Liu, XZ; Lv, ZC; Peng, YH
Year
2012
Is Peer Reviewed?
Yes
Journal
Experimental and Toxicologic Pathology
ISSN:
0940-2993
EISSN:
1618-1433
Volume
64
Issue
7-8
Page Numbers
743-749
Language
English
PMID
21435852
DOI
10.1016/j.etp.2011.01.009
Web of Science Id
WOS:000311073100011
Abstract
Ficus hirta Vahl. (Wuzhimaotao) is widely used as a folk medicine by Hakka people in southern China. In order to ascertain if any major fraction can be attributed to have pronounced anticancer effect, extracts of Wuzhimaotao on cytotoxic and apoptosis of HeLa cell lines were evaluated. HeLa cells were cultured and incubated with different concentrations of crude aqueous extracts (CAE), ethyl acetate extracts (EAE), and butyl alcohol extracts (BAE). It showed CAE, EAE, and BAE decreased cell viability on HeLa cells as a dose-dependent manner, and induced a sub-G1 peak in flow cytometry histogram of treated cells compared to the control. Apoptotic cell death is involved in CAE, EAE, and BAE toxicity, with EAE having a significant decrease in G1 population. An over all analysis of results showed that Wuzhimaotao extracts exert antiproliferative action and growth inhibition on HeLa cells through apoptosis induction which indicates its anticancer properties and deserves further investigation.
Keywords
Ficus hirta Vahl.; Cytotoxicity; Apoptosis; HeLa cells
Tags
IRIS
•
n-Butanol
Database searches
Pubmed
WOS
Source – January 2013 (private)
Pubmed - 1/2013
WOS - 1/2013
Merged reference set - 1/2013
Database Searches - March 2014 (private)
WOS – 3/2014
Excluded (not pertinent)
Use in sample prep or assay
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity